Inventor · disambiguated record
Michael Limmert
Also filed as: LIMMERT MICHAEL
12 granted patents·4 pending applications·46 citations·filing 2005–2022
87Inventor score
Top patents by PatentIndex Score
16 records- 0188US8134146B2Heterocyclic radical or diradical, the dimers, oligomers, polymers, dispiro compounds and polycycles thereof, the use thereof, organic semiconductive material and electronic or optoelectronic componentLIMMERT MICHAEL·Filed 2007·Granted Mar 13, 2012·9 cites·13 claims
- 0287US8920944B2Use of a precursor of an N-dopant for doping an organic semiconductive material, precursor and electronic or optoelectronic componentLIMMERT MICHAEL·Filed 2008·Granted Dec 30, 2014·7 cites·13 claims
- 0385US8809549B2Esters of bendamustine and related compounds, and medical use thereofSCHICKANEDER HELMUT DR·Filed 2013·Granted Aug 19, 2014·8 cites·8 claims
- 0484US8258501B2Use of a metal complex as an n-Dopant for an organic semiconducting matrix material, organic of semiconducting material and electronic component, and also a dopant and ligand and process for producing sameWERNER ANSGAR·Filed 2005·Granted Sep 4, 2012·13 cites·51 claims
- 0581US8431046B2Use of heterocyclic radicals for doping organic semiconductorsZEIKA OLAF·Filed 2007·Granted Apr 30, 2013·5 cites·6 claims
- 0669US10442773B2Amorphous letermovir and solid pharmaceutical formulations thereof for oral administrationAICURIS ANTI INFECTIVE CURES GMBH·Filed 2014·Granted Oct 15, 2019·1 cites·18 claims
- 0768US9118019B2Heterocyclic radical or diradical, the dimers, oligomers, polymers, dispiro compounds and polycycles thereof, the use thereof, organic semiconductive material and electronic or optoelectronic componentLIMMERT MICHAEL·Filed 2012·Granted Aug 25, 2015·2 cites·15 claims
- 0867US9156868B2Aryl-substituted and/or heteroaryl-substituted main group element halides and/or pseudohalides, use of main group element halides and/or pseudohalides, organic semiconducting matrix material, electronic and optoelectronic componentsZEIKA OLAF·Filed 2008·Granted Oct 13, 2015·1 cites·10 claims
- 0947US10526290B2Bendamustine derivatives and related compounds, and medical use thereof in cancer therapySYNBIAS PHARMA AG·Filed 2013·Granted Jan 7, 2020·0 cites·7 claims
- 1045US2025154160A1Method of making buprenorphine and precursor compounds thereofAREVIPHARMA GMBH·Filed 2022·Application pending·0 cites
- 1144US10294208B2Bendamustine derivatives and related compounds, and medical use thereof in cancer therapySCHICKANEDER HELMUT·Filed 2017·Granted May 21, 2019·0 cites·15 claims
- 1243US9065055B2Method for preparing doped organic semiconductor materials and formulation utilized thereinZEIKA OLAF·Filed 2007·Granted Jun 23, 2015·0 cites·13 claims
- 1342US2014356314A13-[3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complexAREVIPHARMA GMBH·Filed 2014·Application pending·0 cites
- 1441US2016185793A1Method for the purification of epothilones via crystallizationSANDOZ AG·Filed 2014·Application pending·0 cites
- 1540US9040697B2Process for the production of moxonidineAREVIPHARMA GMBH·Filed 2014·Granted May 26, 2015·0 cites·14 claims
- 1635US2013184471A1Process for the preparation of bendamustine hydrochloride and related compoundsAREVIPHARMA GMBH·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Limmert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →